KIF11 and neoplasm: This makes KIF11/Eg5, a human kinesin-5 ortholog, an attractive target for cancer chemotherapeutics, and several chemicals that interfere with its activity (kinesin-5 inhibitors or K5Is), and hopefully would impede proliferation of tumor cells [3–5], have been developed.